Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation

• Published in: International journal of molecular sciences 2017-05, Vol.18 (5), p.973
• Main Authors: Fort-Gallifa, Isabel, Hernández-Aguilera, Anna, García-Heredia, Anabel, Cabré, Noemí, Luciano-Mateo, Fedra, Simó, Josep M, Martín-Paredero, Vicente, Camps, Jordi, Joven, Jorge
• Format: Article
• Language: English
• Subjects: Aged; Arteries; atherosclerosis; Biochemical markers; Biochemistry; Biomarkers - blood; Biomarkers - metabolism; Breath tests; C-reactive protein; Case-Control Studies; Chemical compounds; Correlation; Diagnostic systems; Disease; Displacement; Endothelium, Vascular - metabolism; F2-isoprostanes; Female; Femoral Artery - metabolism; Femur; Galectin 3 - blood; Galectin 3 - metabolism; Galectin-3; Humans; Inflammation; Inflammation - blood; Isoprostanes; Localization; Male; Markers; Middle Aged; Oxidative Stress; Pathogenesis; Patients; Peripheral Arterial Disease - blood; Peripheral Arterial Disease - metabolism; Peripheral Arterial Disease - pathology; peripheral artery disease; Plasmas (physics); Popliteal Artery - metabolism; Stress concentration; Vascular diseases; Vein & artery diseases
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms18050973

Galectin-3 is a modulator of oxidative stress, inflammation, and fibrogenesis involved in the pathogenesis of vascular diseases. The present study sought to characterize, in patients with peripheral artery disease (PAD), the localization of galectin-3 in arterial tissue, and to analyze the relationships between the circulating levels of galectin-3 and oxidative stress and inflammation. It also sought to compare the diagnostic accuracy of galectin-3 with that of other biochemical markers of this disease. We analyzed femoral or popliteal arteries from 50 PAD patients, and four control arteries. Plasma from 86 patients was compared with that from 72 control subjects. We observed differences in the expression of galectin-3 in normal arteries, and arteries from patients with PAD, with a displacement of the expression from the adventitia to the media, and the intima. In addition, plasma galectin-3 concentration was increased in PAD patients, and correlated with serologic markers of oxidative stress (F2-isoprostanes), and inflammation [chemokine (C-C motif) ligand 2, C-reactive protein, β-2-microglobulin]. We conclude that the determination of galectin-3 has good diagnostic accuracy in the assessment of PAD and compares well with other analytical parameters currently in use.